Nanoformulation of Spirooxindole and Methods for Treating Hepatocellular Carcinoma
<b>Objectives:</b> This in vivo study introduces a newly developed spirooxindole derivative that is deemed safe and effective as a potential targeted therapy for various cancers. <b>Methods:</b> Extensive in vivo investigations, including histopathology, immunohistochemistry,...
Saved in:
Main Authors: | Assem Barakat, Fardous F. El-Senduny, Mohammad Shahidul Islam, Abdullah Mohammed Al-Majid, Yaseen A. M. M. Elshaier, Eman A. Mazyed, Farid A. Badria |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/17/1/93 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanoformulation of Polymyxin E Through Complex Coacervation: A Pharmacokinetic Analysis
by: Xiaobao Chen, et al.
Published: (2025-01-01) -
CENPN contributes to pancreatic carcinoma progression through the MDM2-mediated p53 signaling pathway
by: Ming Xu, et al.
Published: (2024-04-01) -
Dual EMCV-IRES-integrated dengue virus can express an exogenous gene and cellular Mdm2 integration suppresses the dengue viral replication
by: Tadahisa Teramoto
Published: (2025-01-01) -
Association between ТР53, MDM2 and NQO1 gene polymorphisms and viral load among women with human papillomavirus
by: A.H. AlBosale, et al.
Published: (2022-03-01) -
Gliadin encapsulated PCOs nanoformulation: An effective therapeutic option for metastatic breast cancer
by: Sant Lal, et al.
Published: (2025-06-01)